Purification of HBV antigens for use in vaccines

Details for Australian Patent Application No. 2001282073 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Van Opstel, Omer; Serantoni, Michelle; Schu, Peter; De Heyder, Koen

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001282073

PCT Pub. Number WO02/12287

Priority 0101334 18.01.01 GB; 0019728 10.08.00 GB

Filing date 7 August 2001

Wipo publication date 18 February 2002

Acceptance publication date 20 January 2005

International Classifications

C07K 014/02 Peptides having more than 20 amino acids

C07K 001/36 General processes for the preparation of peptides

A61K 039/29 Medicinal preparations containing antigens or antibodies - Hepatitis virus

Event Publications

20 January 2005 Application Accepted

  Published as AU-B-2001282073

19 May 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001282074

2001282072